BIOTECH STOCKS LEVEL OUTAfter charting an erratic course through June, when the AMEXBiotechnology Index fluctuated in a wide range from 137.67 to162.57, biotechnology stocks seem to have leveled out in earlyJuly. On Wednesday, the index dropped 1.79 to close at 147.32.

On a broader front, the Dow Jones industrial average fell 1.89to 3,293.28 on Wednesday. The NASDAQ composite index wasup 0.16 for the day to 557.57.

On Tuesday, when the Dow average plummeted 44 points andthe NASDAQ index fell 5.76, the AMEX Biotechnology Index wasrelatively peaceful, dipping just 0.70 dip.

The only biotechnology stock to move more than $2 onWednesday was Tocor II, Inc. (NASDAQ:TOCRZ), up $2.25 to$15.50 on very light trading. In addition, Amgen Inc. (AMGN)closed down $1.75 to $61, Genzyme Corp. (GENZ) lost $1.75 to$48.50, and Somatogen Inc. (SMTG) fell $1.75 to $26.

(c) 1997 American Health Consultants. All rights reserved.